SCHEMBL7527586

SCHEMBL7527586

C1=CC(c2ccccc2)(c2ccccc2)Oc2c1c(-c1cccs1)cc1ccccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.38
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
ATM Q13315 1/20 0.36
MEN1 O00255 5/20 0.34
KMT2A Q03164 5/20 0.34
HPGD P15428 5/20 0.34
ALDH1A1 P00352 4/20 0.34
F2 P00734 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
RECQL P46063 1/20 0.34
ADORA2A P29274 3/20 0.33
TMIGD3 P0DMS9 2/20 0.33
ADORA1 P30542 2/20 0.33
KDM4E B2RXH2 6/20 0.33
MAPT P10636 4/20 0.33
GAA P10253 3/20 0.33
GPR35 Q9HC97 2/20 0.32
PKM P14618 1/20 0.32
RPS6KB2 Q9UBS0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7522579 0.82 MEN1 (0.47) MEN1KMT2AHPGDALDH1A1RECQL
SCHEMBL8978583 0.76 NPC1 (0.35) NPC1RAB9AMEN1KMT2AHPGD
SCHEMBL5543986 0.74 GPR84 (0.33) MEN1KMT2ARECQLGPR84
SCHEMBL14437373 0.73 MEN1 (0.32) MEN1KMT2ARECQLGPR84
SCHEMBL7525130 0.71 GPR84 (0.58) NPC1RAB9AMEN1KMT2AHPGD
SCHEMBL7530261 0.71 GPR84 (0.43) ATMMEN1KMT2AHPGDALDH1A1
SCHEMBL9185542 0.70 HSD17B10 (0.33) NPC1RAB9AMAPTPOLB
SCHEMBL10102260 0.69 GPR84 (0.34) GPR84
SCHEMBL1699832 0.67 ALDH1A1 (0.34) NPC1MEN1KMT2AHPGDALDH1A1
SCHEMBL14267935 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020173667-A1 NOVEL AROMATIC SUBSTITUTED NAPHTHOPYRANS TRANSITIONS OPTICAL LIMITED (IE) 2002-11-21 US claimed
US-6478989-B1 Aromatic substituted naphthopyrans TRANSITIONS OPTICAL, INC. 2002-11-12 US claimed
EP-1017690-B1 NOVEL AROMATIC SUBSTITUTED NAPHTHOPYRANS PPG IND OHIO INC (US) 2001-12-05 EP claimed
US-20020173667-A1 NOVEL AROMATIC SUBSTITUTED NAPHTHOPYRANS TRANSITIONS OPTICAL LIMITED (IE) 2002-11-21 US disclosed
US-6478989-B1 Aromatic substituted naphthopyrans TRANSITIONS OPTICAL, INC. 2002-11-12 US disclosed
EP-1017690-B1 NOVEL AROMATIC SUBSTITUTED NAPHTHOPYRANS PPG IND OHIO INC (US) 2001-12-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020173667-A1 NOVEL AROMATIC SUBSTITUTED NAPHTHOPYRANS TYR, B3GNT2, PAH MAOB 656/4885NPC1 1219/4885RAB9A 3013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.